4161 |
7LO6 |
HG_E |
17b Fab |
HIV-1 BG505 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1038/s41467-021-21816-x |
4162 |
7LO6 |
JI_C |
17b Fab |
HIV-1 BG505 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1038/s41467-021-21816-x |
4163 |
7LO6 |
LK_A |
17b Fab |
HIV-1 BG505 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1038/s41467-021-21816-x |
4164 |
7LO7 |
HL_Z |
Fab25 Fab |
Quinolone resistance protein NorA |
Staphylococcus aureus, Homo sapiens |
EM |
3.74 | 10.1038/s41589-022-00994-9 |
4165 |
7LO8 |
HL_Z |
Fab36 Fab |
Quinolone resistance protein NorA |
Staphylococcus aureus, Homo sapiens |
EM |
3.16 | 10.1038/s41589-022-00994-9 |
4166 |
7LOK |
ML_C |
17b Fab |
HIV-1 BG505 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens, Leiurus quinquestriatus hebraeus |
EM |
3.9 | 10.1038/s41467-021-21816-x |
4167 |
7LOK |
KJ_A |
17b Fab |
HIV-1 BG505 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens, Leiurus quinquestriatus hebraeus |
EM |
3.9 | 10.1038/s41467-021-21816-x |
4168 |
7LOP |
WV_Z |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1126/science.abh1139 |
4169 |
7LOP |
BC_A |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1126/science.abh1139 |
4170 |
7LOP |
HL_A |
CV05-163 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1126/science.abh1139 |
4171 |
7LOP |
XY_Z |
CV05-163 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.25 | 10.1126/science.abh1139 |
4172 |
7LPN |
H_G |
llama J3 VHH |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp160 |
Human immunodeficiency virus 1, Lama glama |
EM |
3.61 | 10.1016/j.str.2022.03.012 |
4173 |
7LPN |
D_C |
llama J3 VHH |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp160 |
Human immunodeficiency virus 1, Lama glama |
EM |
3.61 | 10.1016/j.str.2022.03.012 |
4174 |
7LPN |
I_F |
llama J3 VHH |
HIV-1 BG505 DS-SOSIP.664 envelope glycoprotein - gp160 |
Human immunodeficiency virus 1, Lama glama |
EM |
3.61 | 10.1016/j.str.2022.03.012 |
4175 |
7LQ7 |
FG_E |
CV503 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |
4176 |
7LQ7 |
CD_B |
CV503 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |
4177 |
7LQ7 |
HL_A |
CV503 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |
4178 |
7LQ7 |
PQ_A |
COVA1-16 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |
4179 |
7LQ7 |
TU_B |
COVA1-16 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |
4180 |
7LQ7 |
yz_E |
COVA1-16 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.4 | 10.1126/scitranslmed.abj5413 |